Skip to search formSkip to main contentSkip to account menu

ormeloxifene

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Menorrhagia is an abnormal vaginal bleeding. Ormeloxifene is anti proliferative drugs which reduce production of various… 
2015
2015
Background: Menstrual disorders hospital referrals. Dysfunctional Uterine Bleeding is defined as ab absence of organic disease… 
2013
2013
OBJECTIVE This study was carried out to evaluate the efficacy of Ormeloxifene in the pharmacological management of dysfunctional… 
2013
2013
The study was undertaken to assess the efficacy, safety and acceptability of ormeloxifene in the medical management of… 
2011
2011
Objective: To find the effectiveness of ormeloxifene vs medroxyprogesterone acetate (MPA) to reduce blood loss in dysfunctional… 
2010
2010
Background: Ormeloxifene, a third generation selective estrogen receptor modulator, has been claimed to ameliorate symptoms of… 
Highly Cited
2009
Highly Cited
2009
Objective:  To assess the efficacy and safety of ormeloxifene (centchroman) in the medical management of menorrhagia. 
2004
2004
OBJECTIVE - To evaluate the efficacy of Ormeloxifene for dysfunctional menorrhagia (DUB). METHODS Eighty five women aged 30 to 51…